Anti-U1 RNP Ab (RDL)

Sample type: Serum
Optimal result: 0 – 20 Units

Elevated Anti-U1 RNP antibodies are primarily associated with Mixed Connective Tissue Disease (MCTD), serving as a key indicator and aiding in distinguishing MCTD from other autoimmune disorders like lupus and scleroderma. While high levels are most specific to MCTD, these antibodies can also be present in lower concentrations in other autoimmune diseases. The presence and level of Anti-U1 RNP antibodies may correlate with disease activity, especially in MCTD, influencing symptom severity and guiding treatment strategies. However, it's important to consider these results in the context of the patient's overall clinical symptoms and other laboratory findings, as elevated levels are not exclusively indicative of autoimmune disorders and can sometimes be found in individuals without any autoimmune disease.

The Anti-U1 RNP (Ribonucleoprotein) Antibody test is a specific diagnostic tool used in the evaluation of connective tissue diseases. This test detects antibodies against the U1 RNP, a component of a small nuclear ribonucleoprotein complex involved in RNA processing. The presence of anti-U1 RNP antibodies is particularly significant in the diagnosis of mixed connective tissue disease (MCTD), a disorder that exhibits features of several connective tissue diseases like systemic lupus erythematosus, scleroderma, and polymyositis.

The Anti-U1 RNP (Ribonucleoprotein) Antibody test is a specific diagnostic tool used in the evaluation of connective tissue diseases. This test detects antibodies against the U1 RNP, a component of a small nuclear ribonucleoprotein complex involved in RNA processing. The presence of anti-U1 RNP antibodies is particularly significant in the diagnosis of mixed connective tissue disease (MCTD), a disorder that exhibits features of several connective tissue diseases like systemic lupus erythematosus, scleroderma, and polymyositis.

Patients with MCTD typically have high levels of these antibodies. While anti-U1 RNP antibodies can be found in other conditions, such as lupus and scleroderma, their high concentration is more specific to MCTD. The test is valuable for differentiating MCTD from other similar disorders, aiding in accurate diagnosis and treatment. It's important to interpret the results in conjunction with clinical symptoms and other laboratory findings, as these antibodies can sometimes be present in individuals without any autoimmune disease.

Anti-U1 RNP Ab (RDL)
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Anti-U1 RNP Ab (RDL) — 10,000+ markers explained
One Anti-U1 RNP Ab (RDL) result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro